TRICIDA INC's ticker is TCDA and the CUSIP is 89610F101. A total of 2 filers reported holding TRICIDA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $24,036 | -99.9% | 157,200 | -90.6% | 0.00% | -100.0% |
Q3 2022 | $17,578,000 | +108.1% | 1,677,242 | +92.3% | 0.07% | +94.4% |
Q2 2022 | $8,445,000 | -46.6% | 872,400 | -54.7% | 0.04% | -42.9% |
Q1 2022 | $15,825,000 | -49.5% | 1,925,185 | -41.3% | 0.06% | -49.6% |
Q4 2021 | $31,340,000 | +38.1% | 3,278,236 | -33.0% | 0.12% | +25.0% |
Q3 2021 | $22,689,000 | +9.1% | 4,889,949 | +1.6% | 0.10% | +7.5% |
Q2 2021 | $20,801,000 | +48.1% | 4,814,949 | +81.4% | 0.09% | +40.9% |
Q1 2021 | $14,042,000 | +28.2% | 2,654,361 | +119.6% | 0.07% | +17.9% |
Q3 2020 | $10,952,000 | -38.6% | 1,208,800 | +86.2% | 0.06% | -51.7% |
Q2 2020 | $17,836,000 | +3608.1% | 649,051 | +2867.9% | 0.12% | +2800.0% |
Q1 2020 | $481,000 | -91.5% | 21,869 | -85.5% | 0.00% | -86.7% |
Q4 2019 | $5,685,000 | -34.6% | 150,633 | -46.5% | 0.03% | -43.4% |
Q3 2019 | $8,697,000 | +220.8% | 281,724 | +310.1% | 0.05% | +278.6% |
Q2 2019 | $2,711,000 | -39.7% | 68,700 | -41.0% | 0.01% | -30.0% |
Q1 2019 | $4,494,000 | -36.5% | 116,360 | -61.2% | 0.02% | -42.9% |
Q4 2018 | $7,074,000 | – | 300,000 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Orbimed Advisors | 9,614,280 | $362,843,000 | 5.18% |
Redmile Group, LLC | 2,129,100 | $80,352,000 | 1.92% |
Burrage Capital Management LLC | 70,653 | $2,666,000 | 1.79% |
Avoro Capital Advisors LLC | 1,560,000 | $58,874,000 | 1.73% |
Opaleye Management Inc. | 194,000 | $7,303,000 | 1.43% |
Cormorant Asset Management, LP | 927,975 | $35,022,000 | 1.40% |
Duquesne Family Office | 688,344 | $25,978,000 | 0.76% |
H2O AM LLP | 67,991 | $2,566,000 | 0.61% |
Artal Group S.A. | 360,000 | $13,586,000 | 0.52% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 37,000 | $1,393,000 | 0.50% |